Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

Update Il y a 4 ans
Reference: NCT00220155

Woman and Man

Extract

To assess the efficacy and safety of gemcitabine given by fixed dose rate intravenous infusion in patients with pretreated metastatic colorectal cancer.


Inclusion criteria

  • Colorectal Cancer

Links